RecruitingPhase III🇵🇱 PolandEN originalMelanomaMetastatic / advanced

VO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs [IGNYTE-3]

⚠️

This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.

About the trial

This is a randomized, controlled, multicenter, open-label Phase 3 clinical study comparing VO in combination with nivolumab versus Physician's Choice treatment for patients with unresectable Stage IIIb-IV cutaneous melanoma whose disease progressed on an anti PD-1 and an anti-CTLA-4 containing regimen (administered either as a combination regimen or in sequence) or who are not candidates for treatment with an anti-CTLA-4 therapy.

Original English text from ClinicalTrials.gov

Who can (and can't) join

✓ Qualifies

  • Wiek 12 lat lub więcej
  • Potwierdzona diagnoza czerniaka skóry, który nie może być całkowicie usunięty chirurgicznie lub rozprzestrzenił się na inne części ciała (stadium IIIb-IV)
  • Choroba postępowała podczas leczenia dwoma rodzajami leków immunologicznych (anti-PD-1 i anti-CTLA-4)
  • Wcześniejsze leczenie anti-PD-1 trwało co najmniej 8 tygodni
  • Postęp choroby potwierdzony badaniami kontrolnymi w odstępie 4 tygodni
  • Pacjenci, którzy nie mogą otrzymywać leków anti-CTLA-4 z powodu innych schorzeń lub wcześniejszych efektów ubocznych, mogą uczestniczyć jeśli choroba postępuje na leczeniu anti-PD-1

Simplified criteria — AI translation

Trial details

Minimum age
12 Years
Last updated (source)
July 15, 2026
Sex
No restrictions

Therapies / drugs in trial

Locations (81)

Banner MD Anderson Cancer Center

Gilbert, United States

UC San Diego Moores Cancer Center

La Jolla, United States

The Angeles Clinic and Research Institute

Los Angeles, United States

USC Norris Comprehensive Cancer Center

Los Angeles, United States

UCLA Department of Medicine - Hematology/Oncology

Los Angeles, United States

UC Irvine Health, Chao Family Comprehensive Cancer Center

Orange, United States

Stanford Cancer Institute

Palo Alto, United States

Sutter Medical Group

Sacramento, United States

San Francisco Oncology Associates

San Francisco, United States

UCSF Helen Diller Family Comprehensive Cancer Center

San Francisco, United States

University of Colorado Hospital - Anschutz Cancer Pavilion

Aurora, United States

The Melanoma and Skin Cancer Institute

Englewood, United States

MedStar Washington Hospital Center

Washington D.C., United States

Memorial Cancer Institute at Memorial Regional Hospital

Hollywood, United States

Baptist MD Anderson Cancer Center

Jacksonville, United States

Moffitt Cancer Center

Tampa, United States

Winship Cancer Institute, Emory University

Atlanta, United States

Northwestern Memorial Hospital

Chicago, United States

Advocate Lutheran General Hospital

Park Ridge, United States

University of Iowa

Iowa City, United States

University of Kansas Cancer Center

Westwood, United States

University of Louisville Brown Cancer Center

Louisville, United States

Henry Ford Cancer - Detroit (Brigitte Harris Cancer Pavilion)

Detroit, United States

Corewell Health

Grand Rapids, United States

University of Minnesota

Minneapolis, United States

Dartmouth Hitchcock Cancer Center

Lebanon, United States

MD Anderson Cancer Center at Cooper

Camden, United States

Hackensack University Medical Center

Hackensack, United States

Morristown Medical Center - Atlantic Health System

Morristown, United States

Roswell Park Cancer Institute

Buffalo, United States

Northwell Health, R.J. Zuckerberg Cancer Center

Lake Success, United States

Stony Brook University Cancer Center

Stony Brook, United States

Montefiore Medical Center

The Bronx, United States

University of North Carolina at Chapel Hill

Chapel Hill, United States

Duke Cancer Center

Durham, United States

The Ohio State University- Martha Morehouse Tower

Columbus, United States

Thomas Jefferson University

Philadelphia, United States

Fox Chase Cancer Center

Philadelphia, United States

UPMC

Pittsburgh, United States

Rhode Island Hospital

Providence, United States

West Cancer Center and Research Institute

Germantown, United States

University of Tennessee

Knoxville, United States

Texas Oncology

Dallas, United States

University of Texas Southwestern Medical Center

Dallas, United States

The University of Texas MD Anderson Cancer Center

Houston, United States

Intermountain Health

Murray, United States

Huntsman Cancer Institute

Salt Lake City, United States

St. George Regional Hospital

St. George, United States

University of Vermont Medical Center

Burlington, United States

West Virginia University

Morgantown, United States

CHU de Bordeaux, Hôpital Saint-André

Bordeaux, France

CHU de Lille

Lille, France

Hopital de La Timone

Marseille, France

CHU Nice

Nice, France

Hôpital Saint Louis - AP-HP

Paris, France

Hospices Civils de Lyon (HCL) - Centre Hospitalier Lyon-Sud

Pierre-Bénite, France

Institut Gustave Roussy

Villejuif, France

Charité - Universitätsmedizin Berlin

Berlin, Germany

University Hospital Carl Gustav Carus Dresden

Dresden, Germany

Helios Klinik

Erfurt, Germany

Universitätsklinikum Essen

Essen, Germany

Universitätsklinikum Medical Center

Hamburg, Germany

Universitätsklinikum Hospital Heidelberg

Heidelberg, Germany

University of Kiel

Kiel, Germany

Universitatsklinikum Mainz Hautklinik und Poliklinik

Mainz, Germany

LMU München - Klinik and Poliklinik für Dermatologie und Allergologie, Dermatoonkologie

München, Germany

Universitätsklinikum of Tübingen

Tübingen, Germany

National and Kapodistrian University of Athens, General Hospital of Athens "Laiko"

Athens, Greece

Uniwersyteckie Centrum Kliniczne

Gdansk, Poland

Maria Sklodowska-Curie National Research Institute of Oncology

Warsaw, Poland

Hospital Universitari Vall d'Hebron

Barcelona, Spain

Hospital Clinic de Barcelona

Barcelona, Spain

Hospital Clínico Universitario Virgen de la Arrixaca

El Palmar, Spain

Clinica Universidad de Navarra - Madrid

Madrid, Spain

Hospital Universitario 12 de Octubre

Madrid, Spain

Clinica Universidad de Navarra - Pamplona

Pamplona, Spain

Clatterbridge Cancer Centre NHS Foundation Trust

Liverpool, United Kingdom

Royal Free London NHS Foundation Trust - Royal Free Hospital

London, United Kingdom

Guy's & St. Thomas' NHS Foundation Trust

London, United Kingdom

The Royal Marsden NHS Foundation Trust

London, United Kingdom

The Christie NHS Foundation Trust

Manchester, United Kingdom

Trial contact

Clinical Trials at Replimune

Contact information from ClinicalTrials.gov. Contact in English.

Share this trial

Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/16/2026.

You can help another person

We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.